Brevan Howard Capital Management’s Zimmer Biomet ZBH Stock Holding History

Brevan Howard Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,445	Closed	-$220K	–	2556
2025 Q4	$220K	Sell	2,445 -4,025	-62%	-$382K	﹤0.01%	1530
2025 Q3	$637K	Buy	6,470 +1,632	+34%	+$162K	﹤0.01%	1156
2025 Q2	$441K	Buy	+4,838	New	+$468K	﹤0.01%	1407
2025 Q1	–	Sell	-15,043	Closed	-$1.59M	–	1522
2024 Q4	$1.59M	Buy	15,043 +5,178	+52%	+$556K	0.01%	326
2024 Q3	$1.06M	Buy	9,865 +2,945	+43%	+$321K	0.01%	436
2024 Q2	$751K	Buy	+6,920	New	+$816K	0.01%	471

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's ZBH Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,445 shares — an estimated $220K sold.

Brevan Howard Capital Management first reported a position in ZBH in Q2 2024 and held it in 6 quarters. The position peaked at $1.59M in Q4 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Brevan Howard Capital Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Brevan Howard Capital Management sold 2,445 Zimmer Biomet shares in Q1 2026, an estimated $220K.
Brevan Howard Capital Management first reported a position in Zimmer Biomet in Q2 2024 and held it in 6 quarters.
Brevan Howard Capital Management's Zimmer Biomet position peaked at $1.59M in Q4 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.